Insulin by Jet-injection for Hyperglycemia in Diabetes

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Diabetes Mellitus
Interventions
DRUG

insulin aspart

After hyperglycaemia (18-23 mmol/l) has been reached (by decreasing or interrupting exogenous insulin administration 12-24 hours before the experiment), aspart insulin (in a dose of 1.5 times the amount of insulin needed to reduce blood glucose to 6 mmol/l calculated by the insulin-sensitivity factor) will be administered subcutaneously by Insujet pen or conventional insulin pen, on two separate occasions, or vice versa. The injection will be given by the subject under supervision of the research staff.

Trial Locations (1)

6500HB

Radboud University Nijmegen Medical Centre, Nijmegen

All Listed Sponsors
lead

University Medical Center Nijmegen

OTHER

NCT01947556 - Insulin by Jet-injection for Hyperglycemia in Diabetes | Biotech Hunter | Biotech Hunter